{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:00:58Z","timestamp":1761858058109,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108C-161"],"award-info":[{"award-number":["V108C-161"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.pathol.2020.11.009","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T18:46:32Z","timestamp":1616179592000},"page":"740-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies"],"prefix":"10.1016","volume":"53","author":[{"given":"Ching-Fen","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyh-Pyng","family":"Gau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Tsai","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-4291","authenticated-orcid":false,"given":"Chih-Yi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.pathol.2020.11.009_bib1"},{"key":"10.1016\/j.pathol.2020.11.009_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.6004\/jnccn.2017.0007","article-title":"Myelodysplastic syndromes, version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Greenberg","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.pathol.2020.11.009_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","article-title":"Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Tallman","year":"2019","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.pathol.2020.11.009_bib4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/ijlh.12406","article-title":"CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia","volume":"37","author":"Jain","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0609.2000.90047.x","article-title":"CD34\/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes","volume":"64","author":"Baur","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000101709","article-title":"Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic\/myeloproliferative diseases","volume":"74","author":"Orazi","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.pathol.2020.11.009_bib7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/AJCP8M4QQTAZPGRP","article-title":"E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms","volume":"141","author":"Ohgami","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2020.11.009_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.2007.06882.x","article-title":"Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia","volume":"140","author":"Ngo","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2141.2008.07117.x","article-title":"Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia","volume":"141","author":"Ngo","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.009_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.pathol.2020.11.009_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1536867X1001000303","article-title":"Comparing the predictive powers of survival models using Harrell\u2019s C or Somers\u2019 D","volume":"10","author":"Newson","year":"2010","journal-title":"Stata J"},{"key":"10.1016\/j.pathol.2020.11.009_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.seminhematol.2018.07.001","article-title":"The challenging task of enumerating blasts in the bone marrow","volume":"56","author":"Hodes","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3324\/haematol.2012.071449","article-title":"Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes","volume":"98","author":"Senent","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2020.11.009_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-014-2252-4","article-title":"Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts","volume":"94","author":"Font","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00277-012-1565-4","article-title":"Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification","volume":"92","author":"Font","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib17","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1182\/blood-2011-03-342642","article-title":"Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers","volume":"118","author":"Naqvi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.11.009_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9343(98)00032-1","article-title":"Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemia","volume":"104","author":"DeLima","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.pathol.2020.11.009_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1751-553X.2008.01100.x","article-title":"ICSH guidelines for the standardization of bone marrow specimens and reports","volume":"30","author":"Lee","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2020.11.009_bib20","first-page":"154","article-title":"Laboratory aids. Variability of results in differential cell counts on blood smears","volume":"4","author":"Rumke","year":"1960","journal-title":"Triangle"},{"key":"10.1016\/j.pathol.2020.11.009_bib21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: international Working Group on Morphology of Myelodysplastic Syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130252100060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130252100060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:27:25Z","timestamp":1758472045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130252100060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S003130252100060X"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2020.11.009","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2020.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}